Erste Asset Management’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $450K | Hold |
195,000
| – | – | ﹤0.01% | 646 |
|
|
2025
Q1 | $324K | Hold |
195,000
| – | – | ﹤0.01% | 453 |
|
|
2024
Q4 | $441K | Hold |
195,000
| – | – | 0.01% | 449 |
|
|
2024
Q3 | $708K | Hold |
195,000
| – | – | 0.01% | 406 |
|
|
2024
Q2 | $649K | Hold |
195,000
| – | – | 0.01% | 402 |
|
|
2024
Q1 | $1.22M | Hold |
195,000
| – | – | 0.02% | 355 |
|
|
2023
Q4 | $1.29M | Hold |
195,000
| – | – | 0.02% | 353 |
|
|
2023
Q3 | $470K | Hold |
195,000
| – | – | 0.01% | 414 |
|
|
2023
Q2 | $445K | Hold |
195,000
| – | – | 0.01% | 425 |
|
|
2023
Q1 | $343K | Hold |
195,000
| – | – | 0.01% | 460 |
|
|
2022
Q4 | $353K | Buy |
195,000
+75,000
| +63% | +$136K | 0.01% | 449 |
|
|
2022
Q3 | $268K | Hold |
120,000
| – | – | 0.01% | 477 |
|
|
2022
Q2 | $340K | Hold |
120,000
| – | – | 0.01% | 466 |
|
|
2022
Q1 | $508K | Hold |
120,000
| – | – | 0.01% | 434 |
|
|
2021
Q4 | $612K | Hold |
120,000
| – | – | 0.01% | 410 |
|
|
2021
Q3 | $761K | Hold |
120,000
| – | – | 0.02% | 363 |
|
|
2021
Q2 | $785K | Hold |
120,000
| – | – | 0.02% | 369 |
|
|
2021
Q1 | $659K | Buy |
+120,000
| New | +$659K | 0.02% | 365 |
|